Hyaluronic Acid (HA) Raw Material Market Analysis By Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Devices Coating, Biomaterials & Implants, Tissue Preservation), And Segment Forecasts, 2013 - 2024

Published: Mar, 2017 | Pages: 179 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global hyaluronic acid raw material market is expected to reach a value of USD 7.25 billion by 2024, according to a new report by Grand View Research, Inc. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period. 

The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.

Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.

Further Key Findings From the Study Suggest:

•	In 2015, orthopedics was the largest application segment, owing to rising prevalence and incidence of osteoarthritis

•	The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is expected to boost usage over the next 8 years

•	Some of the key market players are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Shiseido Co., Ltd.; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; Genzyme Corporation; F. Hoffmann-La Roche Ltd., Contipro a.s.; Zimmer Biomet; and others

 Table of Content

Chapter 1 Research Methodology
                     1.1 Information Procurement
                          1.1.1 Purchased database:
                          1.1.2 GVR's internal database
                     1.2 Primary Research:
                          1.2.1 List of primary sources include

Chapter 2 Executive Summary
                     2.1 Market Snapshot

Chapter 3 Hyaluronic acid raw material Market Variables, Trends & Scope
                     3.1 Market Segmentation & Scope
                          3.1.1 Market driver analysis
                               3.1.1.1 Demographic shift in the U.S.
                               3.1.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatments
                               3.1.1.3 Growing usage of hyaluronic acid in cosmetic and medical field
                          3.1.2 Market restraint analysis
                               3.1.2.1 High costs and side effects associated with the use of hyaluronic acid
                     3.2 Key Opportunity Priorities
                     3.3 Hyaluronic Acid - SWOT Analysis, By Factor (political & legal, economic and technological)
                     3.4 Industry Analysis - Porter's

Chapter 4 Hyaluronic acid raw material: Application Estimates & Trend Analysis
                     4.1 Hyaluronic Acid Market: Application Movement Analysis
                     4.2 Ophthalmology
                          4.2.1 Ophthalmology market revenue, 2013 - 2024 (USD Million)
                          4.2.2 Ophthalmology market volume, 2013 - 2024 (Thousand Kilograms)
                          4.2.3 Cataract surgery
                               4.2.3.1 Cataract surgery market revenue, 2013 - 2024 (USD Million)
                               4.2.3.2 Cataract surgery market volume, 2013 - 2024 (Thousand Kilograms)
                          4.2.4 Aqueous eye drop
                               4.2.4.1 Aqueous eye drop market revenue, 2013 - 2024 (USD Million)
                               4.2.4.2 Aqueous eye drop market volume, 2013 - 2024 (Thousand Kilograms)
                          4.2.5 Contact lens
                               4.2.5.1 Contact lens market revenue, 2013 - 2024 (USD Million)
                               4.2.5.2 Contact lens market volume, 2013 - 2024 (Thousand Kilograms)
                     4.3 Orthopedics
                          4.3.1 Orthopaedics market revenue, 2013 - 2024 (USD Million)
                          4.3.2 Orthopedics market volume, 2013 - 2024 (Thousand Kilograms)
                          4.3.3 Viscosupplements
                               4.3.3.1 Viscosupplements market revenue, 2013 - 2024 (USD Million)
                               4.3.3.2 Viscosupplements market volume, 2013 - 2024 (Thousand Kilograms)
                          4.3.4 Bone regeneration
                               4.3.4.1 Bone regeneration market revenue, 2013 - 2024 (USD Million)
                               4.3.4.2 Bone regeneration market volume, 2013 - 2024 (Thousand Kilograms)
                     4.4 Dermatology
                          4.4.1 Dermatology market revenue, 2013 - 2024 (USD Million)
                          4.4.2 Dermatology market volume, 2013 - 2024 (Thousand Kilograms)
                          4.4.3 Intradermal injections
                               4.4.3.1 Intradermal market revenue, 2013 - 2024 (USD Million)
                               4.4.3.2 Intradermal market volume, 2013 - 2024 (Thousand Kilograms)
                          4.4.4 Dermal fillers
                               4.4.4.1 Dermal fillers market revenue, 2013 - 2024 (USD Million)
                               4.4.4.2 Dermal filler market volume, 2013 - 2024 (Thousand Kilograms)
                          4.4.5 Wound healing
                               4.4.5.1 Wound healing market revenue, 2013 - 2024 (USD Million)
                               4.4.5.2 Wound healing market volume, 2013 - 2024 (Thousand Kilograms)
                     4.5 Drug Delivery
                          4.5.1 Drug delivery market revenue, 2013 - 2024 (USD Million)
                          4.5.2 Drug delivery market volume, 2013 - 2024 (Thousand Kilograms)
                     4.6 Medical Device Coating
                          4.6.1 Medical device coating market revenue, 2013 - 2024 (USD Million)
                          4.6.2 Medical device coating market volume, 2013 - 2024 (Thousand Kilograms)
                     4.7 Surgical Adhesion Prevention
                          4.7.1 Surgical adhesion prevention market revenue, 2013 - 2024 (USD Million)
                          4.7.2 Surgical adhesion prevention market volume, 2013 - 2024 (Thousand Kilograms)
                     4.8 Biomaterials and Implants
                          4.8.1 Biomaterial and implant market revenue, 2013 - 2024 (USD Million)
                          4.8.2 Biomaterial and implant market volume, 2013 - 2024 (Thousand Kilograms)
                     4.9 Cell and Tissue Preservation
                          4.9.1 Cell and tissue preservation market revenue, 2013 - 2024 (USD Million)
                          4.9.2 Cell and tissue preservation market volume, 2013 - 2024 (Thousand Kilograms)

Chapter 5 Hyaluronic acid raw material: Regional Estimates & Trend Analysis, by Application
                     5.1 Hyaluronic Acid Market Share, by Region, 2015 & 2024
                     5.2 North America
                          5.2.1 North America hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                          5.2.2 North America hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.2.3 U.S
                               5.2.3.1 U.S. hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.2.3.2 U.S. hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.2.4 Canada
                               5.2.4.1 Canada hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.2.4.2 Canada hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                     5.3 Europe
                          5.3.1 Europe hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                          5.3.2 Europe hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.3.3 UK
                               5.3.3.1 UK hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.3.3.2 UK hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.3.4 Germany
                               5.3.4.1 Germany hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.3.4.2 Germany hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                     5.4 Asia Pacific
                          5.4.1 Asia Pacific hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                          5.4.2 Asia Pacific hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.4.3 Japan
                               5.4.3.1 Japan hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.4.3.2 Japan hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.4.4 China
                               5.4.4.1 China hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.4.4.2 China hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                     5.5 Latin America
                          5.5.1 Latin America hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                          5.5.2 Latin America hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.5.3 Brazil
                               5.5.3.1 Brazil hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.5.3.2 Brazil hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.5.4 Mexico
                               5.5.4.1 Mexico hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.5.4.2 Mexico hyaluronic acid market, 2013 - 2024 (Thousand Kilograms)
                     5.6 MEA
                          5.6.1 MEA hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                          5.6.2 MEA hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)
                          5.6.3 South Africa
                               5.6.3.1 South Africa hyaluronic acid market revenue, by application 2013 - 2024 (USD Million)
                               5.6.3.2 South Africa hyaluronic acid market volume, by application 2013 - 2024 (Thousand Kilograms)

Chapter 6 Competitive Landscape
                     6.1 Company Profiles
                          6.1.1 Allergan
                               6.1.1.1 Company overview
                               6.1.1.2 Financial performance
                               6.1.1.3 Product benchmarking
                               6.1.1.4 Strategic initiatives
                          6.1.2 Sanofi
                               6.1.2.1 Company overview
                               6.1.2.2 Financial performance
                               6.1.2.3 Product benchmarking
                               6.1.2.4 Strategic initiatives
                          6.1.3 Genzyme Corporation
                               6.1.3.1 Company overview
                               6.1.3.2 Financial performance
                               6.1.3.3 Product benchmarking
                               6.1.3.4 Strategic initiatives
                          6.1.4 Anika Therapeutics, Inc.
                               6.1.4.1 Company overview
                               6.1.4.2 Financial performance
                               6.1.4.3 Product benchmarking
                               6.1.4.4 Strategic initiatives
                          6.1.5 Salix Pharmaceuticals
                               6.1.5.1 Company overview
                               6.1.5.2 Financial performance
                               6.1.5.3 Product benchmarking
                               6.1.5.4 Strategic initiatives
                          6.1.6 Seikagaku Corporation
                               6.1.6.1 Company overview
                               6.1.6.2 Financial performance
                               6.1.6.3 Product benchmarking
                          6.1.7 F. Hoffmann-La Roche Ltd.
                               6.1.7.1 Company overview
                               6.1.7.2 Financial performance
                               6.1.7.3 Product benchmarking
                               6.1.7.4 Strategic initiatives
                          6.1.8 Galderma S.A.
                               6.1.8.1 Company overview
                               6.1.8.2 Financial performance
                               6.1.8.3 Product benchmarking
                               6.1.8.4 Strategic initiatives
                          6.1.9 Zimmer Biomet
                               6.1.9.1 Company overview
                               6.1.9.2 Financial performance
                               6.1.9.3 Product benchmarking
                          6.1.10 Smith & Nephew
                               6.1.10.1 Company overview
                               6.1.10.2 Financial performance
                               6.1.10.3 Product benchmarking
                               6.1.10.4 Strategic initiatives

Chapter 7 Raw Material Suppliers Competitive Landscape
                     7.1 Company Profiles
                          7.1.1 Lifecore Biomedical
                               7.1.1.1 Company overview
                               7.1.1.2 Financial performance
                               7.1.1.3 Product Benchmarking
                               7.1.1.4 Strategic Initiatives
                          7.1.2 HTL Biotechnology
                               7.1.2.1 Company Overview
                               7.1.2.2 Financial Performance
                               7.1.2.3 Product Benchmarking
                          7.1.3 Shiseido
                               7.1.3.1 Company Overview
                               7.1.3.2 Financial Performance
                               7.1.3.3 Product Benchmarking
                               7.1.3.4 Strategic Initiatives
                          7.1.4 Bloomage Freda Biopharm Co. Ltd.
                               7.1.4.1 Company Overview
                               7.1.4.2 Financial Performance
                               7.1.4.3 Product Benchmarking
                               7.1.4.4 Strategic Initiatives
                          7.1.5 LG Life Sciences
                               7.1.5.1 Company Overview
                               7.1.5.2 Financial Performance
                               7.1.5.3 Product Benchmarking
                               7.1.5.4 Strategic Initiatives
                          7.1.6 Maruha Nichiro, Inc.
                               7.1.6.1 Company Overview
                               7.1.6.2 Financial Performance
                               7.1.6.3 Product Benchmarking
                               7.1.6.4 Strategic Initiatives
                          7.1.7 Contipro
                               7.1.7.1 Company Overview
                               7.1.7.2 Financial Performance
                               7.1.7.3 Product Benchmarking
                               7.1.7.4 Strategic Initiatives
                          7.1.8 Bio-Technology General
                               7.1.8.1 Company Overview
                               7.1.8.2 Financial Performance
                               7.1.8.3 Product Benchmarking
                          7.1.9 Teoxane Laboratories
                               7.1.9.1 Company Overview
                               7.1.9.2 Financial Performance
                               7.1.9.3 Product Benchmarking
                               7.1.9.4 Strategic Initiatives
                          7.1.10 QufuLiyangBiochem Industrial Co. Ltd
                               7.1.10.1 Company Overview
                               7.1.10.2 Financial Performance
                               7.1.10.3 Product Benchmarking
                          7.1.11 Cellbone Technology
                               7.1.11.1 Company Overview
                               7.1.11.2 Financial Performance
                               7.1.11.3 Product Benchmarking
                          7.1.12 Stanford Chemicals
                               7.1.12.1 Company Overview
                               7.1.12.2 Financial Performance
                               7.1.12.3 Product Benchmarking
                          7.1.13 Vesta Ingredients, Inc.
                               7.1.13.1 Company Overview
                               7.1.13.2 Financial Performance
                               7.1.13.3 Product Benchmarking
                     7.2 Hyaluronic Acid Raw Material Manufactures' Market Share, 2015

List of Tables

TABLE 1 Details on cosmetic procedures with hyaluronic acid in the U.S.
TABLE 2 List of Product with PMA approval, 2015-16
TABLE 3 Products and its specifications by Stanford Chemicals
TABLE 4 OTC products in aqueous eye drop
TABLE 5 North America hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 6 North America hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 7 North America ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 8 North America ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 9 North America orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 10 North America orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 11 North America dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 12 North America dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 13 U.S. hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 14 U.S. hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 15 U.S. ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 16 U.S. ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 17 U.S. orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 18 U.S. orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 19 U.S. dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 20 U.S. dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 21 Canada hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 22 Canada hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 23 Canada ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 24 Canada ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 25 Canada orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 26 Canada orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 27 Canada dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 28 Canada dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 29 Europe hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 30 Europe hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 31 Europe ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 32 Europe ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 33 Europe orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 34 Europe orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 35 Europe dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 36 Europe dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 37 Hyaluronic acid containing product, by Brand name in the UK market
TABLE 38 UK hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 39 UK hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 40 UK ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 41 UK ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 42 UK orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 43 UK orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 44 UK dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 45 UK dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 46 Germany hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 47 Germany hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 48 Germany ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 49 Germany ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 50 Germany orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 51 Germany orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 52 Germany dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 53 Germany dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 54 Asia Pacific hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 55 Asia Pacific hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 56 Asia Pacific ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 57 Asia Pacific ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 58 Asia Pacific orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 59 Asia Pacific orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 60 Asia Pacific dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 61 Asia Pacific dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 62 Japan hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 63 Japan hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 64 Japan ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 65 Japan ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 66 Japan orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 67 Japan orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 68 Japan dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 69 Japan dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 70 China hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 71 China hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 72 China ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 73 China ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 74 China orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 75 China orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 76 China dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 77 China dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 78 Latin America hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 79 Latin America hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 80 Latin America ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 81 Latin America ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 82 Latin America orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 83 Latin America orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 84 Latin America dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 85 Latin America dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 86 Brazil hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 87 Brazil hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 88 Brazil ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 89 Brazil ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 90 Brazil orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 91 Brazil orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 92 Brazil dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 93 Brazil dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 94 Mexico hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 95 Mexico hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 96 Mexico ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 97 Mexico ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 98 Mexico orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 99 Mexico orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 100 Mexico dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 101 Mexico dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 102 MEA hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 103 MEA hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 104 MEA ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 105 MEA ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 106 MEA orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 107 MEA orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 108 MEA dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 109 MEA dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 110 South Africa hyaluronic acid market revenue, by application, 2013 - 2024 (USD Million)
TABLE 111 South Africa hyaluronic acid market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 112 South Africa ophthalmology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 113 South Africa ophthalmology market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 114 South Africa orthopedics market revenue, by application, 2013 - 2024 (USD Million)
TABLE 115 South Africa orthopedics market volume, by application, 2013 - 2024 (Thousand Kilograms)
TABLE 116 South Africa dermatology market revenue, by application, 2013 - 2024 (USD Million)
TABLE 117 South Africa dermatology market volume, by application, 2013 - 2024 (Thousand Kilograms)